Back to Search
Start Over
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification.
- Source :
-
European urology [Eur Urol] 2023 Apr; Vol. 83 (4), pp. 301-303. Date of Electronic Publication: 2022 Oct 04. - Publication Year :
- 2023
-
Abstract
- We present the rationale for keeping the "cancer" label for grade group 1 (GG1) prostate cancer. Maintaining GG1 as the lowest grade outweighs the potential benefits that a benign designation may bring. Patient and surgeon education on the vital role of active surveillance for GG1 cancers and avoidance of overtreatment should be the focus rather than such a drastic change in nomenclature.<br /> (Copyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-7560
- Volume :
- 83
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- European urology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36202687
- Full Text :
- https://doi.org/10.1016/j.eururo.2022.09.015